Global Circulating Tumor Cells (CTC) Liquid Biopsy Supply, Demand and Key Producers, 2023-2029
The global Circulating Tumor Cells (CTC) Liquid Biopsy market size is expected to reach $ 2668.9 million by 2029, rising at a market growth of 13.1% CAGR during the forecast period (2023-2029).
North America dominates global circulating tumor cells (CTC) liquid biopsy market. This is majorly due to the growing adoption of the liquid biopsy in the North American region for diagnosis of cancer. There are rapidly growing cases of cancer in US which has contributed in the dominance of North America in the global liquid biopsy market.
This report studies the global Circulating Tumor Cells (CTC) Liquid Biopsy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Circulating Tumor Cells (CTC) Liquid Biopsy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Circulating Tumor Cells (CTC) Liquid Biopsy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Circulating Tumor Cells (CTC) Liquid Biopsy total market, 2018-2029, (USD Million)
Global Circulating Tumor Cells (CTC) Liquid Biopsy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Circulating Tumor Cells (CTC) Liquid Biopsy total market, key domestic companies and share, (USD Million)
Global Circulating Tumor Cells (CTC) Liquid Biopsy revenue by player and market share 2018-2023, (USD Million)
Global Circulating Tumor Cells (CTC) Liquid Biopsy total market by Type, CAGR, 2018-2029, (USD Million)
Global Circulating Tumor Cells (CTC) Liquid Biopsy total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Circulating Tumor Cells (CTC) Liquid Biopsy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include QIAGEN, Bio-Techne, Precision Medical, Aviva Systems Biological, Biocept, Fluxion Biosciences, Greiner Bio-One International GmbH, Ikonisys and Miltenyi Biotec, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Circulating Tumor Cells (CTC) Liquid Biopsy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market, By Region:
1. How big is the global Circulating Tumor Cells (CTC) Liquid Biopsy market?
2. What is the demand of the global Circulating Tumor Cells (CTC) Liquid Biopsy market?
3. What is the year over year growth of the global Circulating Tumor Cells (CTC) Liquid Biopsy market?
4. What is the total value of the global Circulating Tumor Cells (CTC) Liquid Biopsy market?
5. Who are the major players in the global Circulating Tumor Cells (CTC) Liquid Biopsy market?
6. What are the growth factors driving the market demand?
North America dominates global circulating tumor cells (CTC) liquid biopsy market. This is majorly due to the growing adoption of the liquid biopsy in the North American region for diagnosis of cancer. There are rapidly growing cases of cancer in US which has contributed in the dominance of North America in the global liquid biopsy market.
This report studies the global Circulating Tumor Cells (CTC) Liquid Biopsy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Circulating Tumor Cells (CTC) Liquid Biopsy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Circulating Tumor Cells (CTC) Liquid Biopsy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Circulating Tumor Cells (CTC) Liquid Biopsy total market, 2018-2029, (USD Million)
Global Circulating Tumor Cells (CTC) Liquid Biopsy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Circulating Tumor Cells (CTC) Liquid Biopsy total market, key domestic companies and share, (USD Million)
Global Circulating Tumor Cells (CTC) Liquid Biopsy revenue by player and market share 2018-2023, (USD Million)
Global Circulating Tumor Cells (CTC) Liquid Biopsy total market by Type, CAGR, 2018-2029, (USD Million)
Global Circulating Tumor Cells (CTC) Liquid Biopsy total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Circulating Tumor Cells (CTC) Liquid Biopsy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include QIAGEN, Bio-Techne, Precision Medical, Aviva Systems Biological, Biocept, Fluxion Biosciences, Greiner Bio-One International GmbH, Ikonisys and Miltenyi Biotec, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Circulating Tumor Cells (CTC) Liquid Biopsy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Kits & Reagents
- Blood Collection Tubes
- Devices
- Research & Academic Institutes
- Hospitals
- Physician Laboratories
- Others
- QIAGEN
- Bio-Techne
- Precision Medical
- Aviva Systems Biological
- Biocept
- Fluxion Biosciences
- Greiner Bio-One International GmbH
- Ikonisys
- Miltenyi Biotec
- IVDiagnostics
- BioFluidica
- Canopus Medical
- Biolidics
- Creativ MicroTech
- LungLife AI
- Epic Sciences
- Rarecells Diagnostics
- ScreenCell
- Menarini Silicon Biosystems
1. How big is the global Circulating Tumor Cells (CTC) Liquid Biopsy market?
2. What is the demand of the global Circulating Tumor Cells (CTC) Liquid Biopsy market?
3. What is the year over year growth of the global Circulating Tumor Cells (CTC) Liquid Biopsy market?
4. What is the total value of the global Circulating Tumor Cells (CTC) Liquid Biopsy market?
5. Who are the major players in the global Circulating Tumor Cells (CTC) Liquid Biopsy market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
1.2 World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Circulating Tumor Cells (CTC) Liquid Biopsy Total Market by Region (by Headquarter Location)
1.3.1 World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2018-2029)
1.3.3 China Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2018-2029)
1.3.4 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2018-2029)
1.3.5 Japan Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2018-2029)
1.3.6 South Korea Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2018-2029)
1.3.7 ASEAN Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2018-2029)
1.3.8 India Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Circulating Tumor Cells (CTC) Liquid Biopsy Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029)
2.2 World Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Region
2.2.1 World Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Region (2018-2023)
2.2.2 World Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Forecast by Region (2024-2029)
2.3 United States Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029)
2.4 China Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029)
2.5 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029)
2.6 Japan Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029)
2.7 South Korea Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029)
2.8 ASEAN Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029)
2.9 India Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029)
3 WORLD CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY COMPANIES COMPETITIVE ANALYSIS
3.1 World Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Circulating Tumor Cells (CTC) Liquid Biopsy in 2022
3.2.3 Global Concentration Ratios (CR8) for Circulating Tumor Cells (CTC) Liquid Biopsy in 2022
3.3 Circulating Tumor Cells (CTC) Liquid Biopsy Company Evaluation Quadrant
3.4 Circulating Tumor Cells (CTC) Liquid Biopsy Market: Overall Company Footprint Analysis
3.4.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market: Region Footprint
3.4.2 Circulating Tumor Cells (CTC) Liquid Biopsy Market: Company Product Type Footprint
3.4.3 Circulating Tumor Cells (CTC) Liquid Biopsy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Comparison
4.2.1 United States VS China: Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Circulating Tumor Cells (CTC) Liquid Biopsy Companies and Market Share, 2018-2023
4.3.1 United States Based Circulating Tumor Cells (CTC) Liquid Biopsy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, (2018-2023)
4.4 China Based Companies Circulating Tumor Cells (CTC) Liquid Biopsy Revenue and Market Share, 2018-2023
4.4.1 China Based Circulating Tumor Cells (CTC) Liquid Biopsy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, (2018-2023)
4.5 Rest of World Based Circulating Tumor Cells (CTC) Liquid Biopsy Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Circulating Tumor Cells (CTC) Liquid Biopsy Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Kits & Reagents
5.2.2 Blood Collection Tubes
5.2.3 Devices
5.3 Market Segment by Type
5.3.1 World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023)
5.3.2 World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2024-2029)
5.3.3 World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Research & Academic Institutes
6.2.2 Hospitals
6.2.3 Physician Laboratories
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023)
6.3.2 World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2024-2029)
6.3.3 World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 QIAGEN
7.1.1 QIAGEN Details
7.1.2 QIAGEN Major Business
7.1.3 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.1.4 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 QIAGEN Recent Developments/Updates
7.1.6 QIAGEN Competitive Strengths & Weaknesses
7.2 Bio-Techne
7.2.1 Bio-Techne Details
7.2.2 Bio-Techne Major Business
7.2.3 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.2.4 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Bio-Techne Recent Developments/Updates
7.2.6 Bio-Techne Competitive Strengths & Weaknesses
7.3 Precision Medical
7.3.1 Precision Medical Details
7.3.2 Precision Medical Major Business
7.3.3 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.3.4 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Precision Medical Recent Developments/Updates
7.3.6 Precision Medical Competitive Strengths & Weaknesses
7.4 Aviva Systems Biological
7.4.1 Aviva Systems Biological Details
7.4.2 Aviva Systems Biological Major Business
7.4.3 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.4.4 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Aviva Systems Biological Recent Developments/Updates
7.4.6 Aviva Systems Biological Competitive Strengths & Weaknesses
7.5 Biocept
7.5.1 Biocept Details
7.5.2 Biocept Major Business
7.5.3 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.5.4 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Biocept Recent Developments/Updates
7.5.6 Biocept Competitive Strengths & Weaknesses
7.6 Fluxion Biosciences
7.6.1 Fluxion Biosciences Details
7.6.2 Fluxion Biosciences Major Business
7.6.3 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.6.4 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Fluxion Biosciences Recent Developments/Updates
7.6.6 Fluxion Biosciences Competitive Strengths & Weaknesses
7.7 Greiner Bio-One International GmbH
7.7.1 Greiner Bio-One International GmbH Details
7.7.2 Greiner Bio-One International GmbH Major Business
7.7.3 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.7.4 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Greiner Bio-One International GmbH Recent Developments/Updates
7.7.6 Greiner Bio-One International GmbH Competitive Strengths & Weaknesses
7.8 Ikonisys
7.8.1 Ikonisys Details
7.8.2 Ikonisys Major Business
7.8.3 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.8.4 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Ikonisys Recent Developments/Updates
7.8.6 Ikonisys Competitive Strengths & Weaknesses
7.9 Miltenyi Biotec
7.9.1 Miltenyi Biotec Details
7.9.2 Miltenyi Biotec Major Business
7.9.3 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.9.4 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Miltenyi Biotec Recent Developments/Updates
7.9.6 Miltenyi Biotec Competitive Strengths & Weaknesses
7.10 IVDiagnostics
7.10.1 IVDiagnostics Details
7.10.2 IVDiagnostics Major Business
7.10.3 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.10.4 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 IVDiagnostics Recent Developments/Updates
7.10.6 IVDiagnostics Competitive Strengths & Weaknesses
7.11 BioFluidica
7.11.1 BioFluidica Details
7.11.2 BioFluidica Major Business
7.11.3 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.11.4 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 BioFluidica Recent Developments/Updates
7.11.6 BioFluidica Competitive Strengths & Weaknesses
7.12 Canopus Medical
7.12.1 Canopus Medical Details
7.12.2 Canopus Medical Major Business
7.12.3 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.12.4 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Canopus Medical Recent Developments/Updates
7.12.6 Canopus Medical Competitive Strengths & Weaknesses
7.13 Biolidics
7.13.1 Biolidics Details
7.13.2 Biolidics Major Business
7.13.3 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.13.4 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Biolidics Recent Developments/Updates
7.13.6 Biolidics Competitive Strengths & Weaknesses
7.14 Creativ MicroTech
7.14.1 Creativ MicroTech Details
7.14.2 Creativ MicroTech Major Business
7.14.3 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.14.4 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Creativ MicroTech Recent Developments/Updates
7.14.6 Creativ MicroTech Competitive Strengths & Weaknesses
7.15 LungLife AI
7.15.1 LungLife AI Details
7.15.2 LungLife AI Major Business
7.15.3 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.15.4 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 LungLife AI Recent Developments/Updates
7.15.6 LungLife AI Competitive Strengths & Weaknesses
7.16 Epic Sciences
7.16.1 Epic Sciences Details
7.16.2 Epic Sciences Major Business
7.16.3 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.16.4 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Epic Sciences Recent Developments/Updates
7.16.6 Epic Sciences Competitive Strengths & Weaknesses
7.17 Rarecells Diagnostics
7.17.1 Rarecells Diagnostics Details
7.17.2 Rarecells Diagnostics Major Business
7.17.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.17.4 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Rarecells Diagnostics Recent Developments/Updates
7.17.6 Rarecells Diagnostics Competitive Strengths & Weaknesses
7.18 ScreenCell
7.18.1 ScreenCell Details
7.18.2 ScreenCell Major Business
7.18.3 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.18.4 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 ScreenCell Recent Developments/Updates
7.18.6 ScreenCell Competitive Strengths & Weaknesses
7.19 Menarini Silicon Biosystems
7.19.1 Menarini Silicon Biosystems Details
7.19.2 Menarini Silicon Biosystems Major Business
7.19.3 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.19.4 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Menarini Silicon Biosystems Recent Developments/Updates
7.19.6 Menarini Silicon Biosystems Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Circulating Tumor Cells (CTC) Liquid Biopsy Industry Chain
8.2 Circulating Tumor Cells (CTC) Liquid Biopsy Upstream Analysis
8.3 Circulating Tumor Cells (CTC) Liquid Biopsy Midstream Analysis
8.4 Circulating Tumor Cells (CTC) Liquid Biopsy Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
1.2 World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Circulating Tumor Cells (CTC) Liquid Biopsy Total Market by Region (by Headquarter Location)
1.3.1 World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2018-2029)
1.3.3 China Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2018-2029)
1.3.4 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2018-2029)
1.3.5 Japan Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2018-2029)
1.3.6 South Korea Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2018-2029)
1.3.7 ASEAN Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2018-2029)
1.3.8 India Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Circulating Tumor Cells (CTC) Liquid Biopsy Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029)
2.2 World Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Region
2.2.1 World Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Region (2018-2023)
2.2.2 World Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Forecast by Region (2024-2029)
2.3 United States Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029)
2.4 China Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029)
2.5 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029)
2.6 Japan Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029)
2.7 South Korea Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029)
2.8 ASEAN Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029)
2.9 India Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029)
3 WORLD CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY COMPANIES COMPETITIVE ANALYSIS
3.1 World Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Circulating Tumor Cells (CTC) Liquid Biopsy in 2022
3.2.3 Global Concentration Ratios (CR8) for Circulating Tumor Cells (CTC) Liquid Biopsy in 2022
3.3 Circulating Tumor Cells (CTC) Liquid Biopsy Company Evaluation Quadrant
3.4 Circulating Tumor Cells (CTC) Liquid Biopsy Market: Overall Company Footprint Analysis
3.4.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market: Region Footprint
3.4.2 Circulating Tumor Cells (CTC) Liquid Biopsy Market: Company Product Type Footprint
3.4.3 Circulating Tumor Cells (CTC) Liquid Biopsy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Comparison
4.2.1 United States VS China: Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Circulating Tumor Cells (CTC) Liquid Biopsy Companies and Market Share, 2018-2023
4.3.1 United States Based Circulating Tumor Cells (CTC) Liquid Biopsy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, (2018-2023)
4.4 China Based Companies Circulating Tumor Cells (CTC) Liquid Biopsy Revenue and Market Share, 2018-2023
4.4.1 China Based Circulating Tumor Cells (CTC) Liquid Biopsy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, (2018-2023)
4.5 Rest of World Based Circulating Tumor Cells (CTC) Liquid Biopsy Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Circulating Tumor Cells (CTC) Liquid Biopsy Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Kits & Reagents
5.2.2 Blood Collection Tubes
5.2.3 Devices
5.3 Market Segment by Type
5.3.1 World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023)
5.3.2 World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2024-2029)
5.3.3 World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Research & Academic Institutes
6.2.2 Hospitals
6.2.3 Physician Laboratories
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023)
6.3.2 World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2024-2029)
6.3.3 World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 QIAGEN
7.1.1 QIAGEN Details
7.1.2 QIAGEN Major Business
7.1.3 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.1.4 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 QIAGEN Recent Developments/Updates
7.1.6 QIAGEN Competitive Strengths & Weaknesses
7.2 Bio-Techne
7.2.1 Bio-Techne Details
7.2.2 Bio-Techne Major Business
7.2.3 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.2.4 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Bio-Techne Recent Developments/Updates
7.2.6 Bio-Techne Competitive Strengths & Weaknesses
7.3 Precision Medical
7.3.1 Precision Medical Details
7.3.2 Precision Medical Major Business
7.3.3 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.3.4 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Precision Medical Recent Developments/Updates
7.3.6 Precision Medical Competitive Strengths & Weaknesses
7.4 Aviva Systems Biological
7.4.1 Aviva Systems Biological Details
7.4.2 Aviva Systems Biological Major Business
7.4.3 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.4.4 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Aviva Systems Biological Recent Developments/Updates
7.4.6 Aviva Systems Biological Competitive Strengths & Weaknesses
7.5 Biocept
7.5.1 Biocept Details
7.5.2 Biocept Major Business
7.5.3 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.5.4 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Biocept Recent Developments/Updates
7.5.6 Biocept Competitive Strengths & Weaknesses
7.6 Fluxion Biosciences
7.6.1 Fluxion Biosciences Details
7.6.2 Fluxion Biosciences Major Business
7.6.3 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.6.4 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Fluxion Biosciences Recent Developments/Updates
7.6.6 Fluxion Biosciences Competitive Strengths & Weaknesses
7.7 Greiner Bio-One International GmbH
7.7.1 Greiner Bio-One International GmbH Details
7.7.2 Greiner Bio-One International GmbH Major Business
7.7.3 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.7.4 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Greiner Bio-One International GmbH Recent Developments/Updates
7.7.6 Greiner Bio-One International GmbH Competitive Strengths & Weaknesses
7.8 Ikonisys
7.8.1 Ikonisys Details
7.8.2 Ikonisys Major Business
7.8.3 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.8.4 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Ikonisys Recent Developments/Updates
7.8.6 Ikonisys Competitive Strengths & Weaknesses
7.9 Miltenyi Biotec
7.9.1 Miltenyi Biotec Details
7.9.2 Miltenyi Biotec Major Business
7.9.3 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.9.4 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Miltenyi Biotec Recent Developments/Updates
7.9.6 Miltenyi Biotec Competitive Strengths & Weaknesses
7.10 IVDiagnostics
7.10.1 IVDiagnostics Details
7.10.2 IVDiagnostics Major Business
7.10.3 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.10.4 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 IVDiagnostics Recent Developments/Updates
7.10.6 IVDiagnostics Competitive Strengths & Weaknesses
7.11 BioFluidica
7.11.1 BioFluidica Details
7.11.2 BioFluidica Major Business
7.11.3 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.11.4 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 BioFluidica Recent Developments/Updates
7.11.6 BioFluidica Competitive Strengths & Weaknesses
7.12 Canopus Medical
7.12.1 Canopus Medical Details
7.12.2 Canopus Medical Major Business
7.12.3 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.12.4 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Canopus Medical Recent Developments/Updates
7.12.6 Canopus Medical Competitive Strengths & Weaknesses
7.13 Biolidics
7.13.1 Biolidics Details
7.13.2 Biolidics Major Business
7.13.3 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.13.4 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Biolidics Recent Developments/Updates
7.13.6 Biolidics Competitive Strengths & Weaknesses
7.14 Creativ MicroTech
7.14.1 Creativ MicroTech Details
7.14.2 Creativ MicroTech Major Business
7.14.3 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.14.4 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Creativ MicroTech Recent Developments/Updates
7.14.6 Creativ MicroTech Competitive Strengths & Weaknesses
7.15 LungLife AI
7.15.1 LungLife AI Details
7.15.2 LungLife AI Major Business
7.15.3 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.15.4 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 LungLife AI Recent Developments/Updates
7.15.6 LungLife AI Competitive Strengths & Weaknesses
7.16 Epic Sciences
7.16.1 Epic Sciences Details
7.16.2 Epic Sciences Major Business
7.16.3 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.16.4 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Epic Sciences Recent Developments/Updates
7.16.6 Epic Sciences Competitive Strengths & Weaknesses
7.17 Rarecells Diagnostics
7.17.1 Rarecells Diagnostics Details
7.17.2 Rarecells Diagnostics Major Business
7.17.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.17.4 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Rarecells Diagnostics Recent Developments/Updates
7.17.6 Rarecells Diagnostics Competitive Strengths & Weaknesses
7.18 ScreenCell
7.18.1 ScreenCell Details
7.18.2 ScreenCell Major Business
7.18.3 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.18.4 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 ScreenCell Recent Developments/Updates
7.18.6 ScreenCell Competitive Strengths & Weaknesses
7.19 Menarini Silicon Biosystems
7.19.1 Menarini Silicon Biosystems Details
7.19.2 Menarini Silicon Biosystems Major Business
7.19.3 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
7.19.4 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Menarini Silicon Biosystems Recent Developments/Updates
7.19.6 Menarini Silicon Biosystems Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Circulating Tumor Cells (CTC) Liquid Biopsy Industry Chain
8.2 Circulating Tumor Cells (CTC) Liquid Biopsy Upstream Analysis
8.3 Circulating Tumor Cells (CTC) Liquid Biopsy Midstream Analysis
8.4 Circulating Tumor Cells (CTC) Liquid Biopsy Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Circulating Tumor Cells (CTC) Liquid Biopsy Players in 2022
Table 12. World Circulating Tumor Cells (CTC) Liquid Biopsy Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Circulating Tumor Cells (CTC) Liquid Biopsy Company Evaluation Quadrant
Table 14. Head Office of Key Circulating Tumor Cells (CTC) Liquid Biopsy Player
Table 15. Circulating Tumor Cells (CTC) Liquid Biopsy Market: Company Product Type Footprint
Table 16. Circulating Tumor Cells (CTC) Liquid Biopsy Market: Company Product Application Footprint
Table 17. Circulating Tumor Cells (CTC) Liquid Biopsy Mergers & Acquisitions Activity
Table 18. United States VS China Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Circulating Tumor Cells (CTC) Liquid Biopsy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share (2018-2023)
Table 23. China Based Circulating Tumor Cells (CTC) Liquid Biopsy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share (2018-2023)
Table 26. Rest of World Based Circulating Tumor Cells (CTC) Liquid Biopsy Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share (2018-2023)
Table 29. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023) & (USD Million)
Table 31. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2024-2029) & (USD Million)
Table 32. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023) & (USD Million)
Table 34. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2024-2029) & (USD Million)
Table 35. QIAGEN Basic Information, Area Served and Competitors
Table 36. QIAGEN Major Business
Table 37. QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 38. QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. QIAGEN Recent Developments/Updates
Table 40. QIAGEN Competitive Strengths & Weaknesses
Table 41. Bio-Techne Basic Information, Area Served and Competitors
Table 42. Bio-Techne Major Business
Table 43. Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 44. Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Bio-Techne Recent Developments/Updates
Table 46. Bio-Techne Competitive Strengths & Weaknesses
Table 47. Precision Medical Basic Information, Area Served and Competitors
Table 48. Precision Medical Major Business
Table 49. Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 50. Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Precision Medical Recent Developments/Updates
Table 52. Precision Medical Competitive Strengths & Weaknesses
Table 53. Aviva Systems Biological Basic Information, Area Served and Competitors
Table 54. Aviva Systems Biological Major Business
Table 55. Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 56. Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Aviva Systems Biological Recent Developments/Updates
Table 58. Aviva Systems Biological Competitive Strengths & Weaknesses
Table 59. Biocept Basic Information, Area Served and Competitors
Table 60. Biocept Major Business
Table 61. Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 62. Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Biocept Recent Developments/Updates
Table 64. Biocept Competitive Strengths & Weaknesses
Table 65. Fluxion Biosciences Basic Information, Area Served and Competitors
Table 66. Fluxion Biosciences Major Business
Table 67. Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 68. Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Fluxion Biosciences Recent Developments/Updates
Table 70. Fluxion Biosciences Competitive Strengths & Weaknesses
Table 71. Greiner Bio-One International GmbH Basic Information, Area Served and Competitors
Table 72. Greiner Bio-One International GmbH Major Business
Table 73. Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 74. Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Greiner Bio-One International GmbH Recent Developments/Updates
Table 76. Greiner Bio-One International GmbH Competitive Strengths & Weaknesses
Table 77. Ikonisys Basic Information, Area Served and Competitors
Table 78. Ikonisys Major Business
Table 79. Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 80. Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Ikonisys Recent Developments/Updates
Table 82. Ikonisys Competitive Strengths & Weaknesses
Table 83. Miltenyi Biotec Basic Information, Area Served and Competitors
Table 84. Miltenyi Biotec Major Business
Table 85. Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 86. Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Miltenyi Biotec Recent Developments/Updates
Table 88. Miltenyi Biotec Competitive Strengths & Weaknesses
Table 89. IVDiagnostics Basic Information, Area Served and Competitors
Table 90. IVDiagnostics Major Business
Table 91. IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 92. IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. IVDiagnostics Recent Developments/Updates
Table 94. IVDiagnostics Competitive Strengths & Weaknesses
Table 95. BioFluidica Basic Information, Area Served and Competitors
Table 96. BioFluidica Major Business
Table 97. BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 98. BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. BioFluidica Recent Developments/Updates
Table 100. BioFluidica Competitive Strengths & Weaknesses
Table 101. Canopus Medical Basic Information, Area Served and Competitors
Table 102. Canopus Medical Major Business
Table 103. Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 104. Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Canopus Medical Recent Developments/Updates
Table 106. Canopus Medical Competitive Strengths & Weaknesses
Table 107. Biolidics Basic Information, Area Served and Competitors
Table 108. Biolidics Major Business
Table 109. Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 110. Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Biolidics Recent Developments/Updates
Table 112. Biolidics Competitive Strengths & Weaknesses
Table 113. Creativ MicroTech Basic Information, Area Served and Competitors
Table 114. Creativ MicroTech Major Business
Table 115. Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 116. Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Creativ MicroTech Recent Developments/Updates
Table 118. Creativ MicroTech Competitive Strengths & Weaknesses
Table 119. LungLife AI Basic Information, Area Served and Competitors
Table 120. LungLife AI Major Business
Table 121. LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 122. LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. LungLife AI Recent Developments/Updates
Table 124. LungLife AI Competitive Strengths & Weaknesses
Table 125. Epic Sciences Basic Information, Area Served and Competitors
Table 126. Epic Sciences Major Business
Table 127. Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 128. Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Epic Sciences Recent Developments/Updates
Table 130. Epic Sciences Competitive Strengths & Weaknesses
Table 131. Rarecells Diagnostics Basic Information, Area Served and Competitors
Table 132. Rarecells Diagnostics Major Business
Table 133. Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 134. Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Rarecells Diagnostics Recent Developments/Updates
Table 136. Rarecells Diagnostics Competitive Strengths & Weaknesses
Table 137. ScreenCell Basic Information, Area Served and Competitors
Table 138. ScreenCell Major Business
Table 139. ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 140. ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. ScreenCell Recent Developments/Updates
Table 142. Menarini Silicon Biosystems Basic Information, Area Served and Competitors
Table 143. Menarini Silicon Biosystems Major Business
Table 144. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 145. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 146. Global Key Players of Circulating Tumor Cells (CTC) Liquid Biopsy Upstream (Raw Materials)
Table 147. Circulating Tumor Cells (CTC) Liquid Biopsy Typical Customers
Table 1. World Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Circulating Tumor Cells (CTC) Liquid Biopsy Players in 2022
Table 12. World Circulating Tumor Cells (CTC) Liquid Biopsy Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Circulating Tumor Cells (CTC) Liquid Biopsy Company Evaluation Quadrant
Table 14. Head Office of Key Circulating Tumor Cells (CTC) Liquid Biopsy Player
Table 15. Circulating Tumor Cells (CTC) Liquid Biopsy Market: Company Product Type Footprint
Table 16. Circulating Tumor Cells (CTC) Liquid Biopsy Market: Company Product Application Footprint
Table 17. Circulating Tumor Cells (CTC) Liquid Biopsy Mergers & Acquisitions Activity
Table 18. United States VS China Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Circulating Tumor Cells (CTC) Liquid Biopsy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share (2018-2023)
Table 23. China Based Circulating Tumor Cells (CTC) Liquid Biopsy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share (2018-2023)
Table 26. Rest of World Based Circulating Tumor Cells (CTC) Liquid Biopsy Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share (2018-2023)
Table 29. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2018-2023) & (USD Million)
Table 31. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2024-2029) & (USD Million)
Table 32. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2018-2023) & (USD Million)
Table 34. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2024-2029) & (USD Million)
Table 35. QIAGEN Basic Information, Area Served and Competitors
Table 36. QIAGEN Major Business
Table 37. QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 38. QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. QIAGEN Recent Developments/Updates
Table 40. QIAGEN Competitive Strengths & Weaknesses
Table 41. Bio-Techne Basic Information, Area Served and Competitors
Table 42. Bio-Techne Major Business
Table 43. Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 44. Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Bio-Techne Recent Developments/Updates
Table 46. Bio-Techne Competitive Strengths & Weaknesses
Table 47. Precision Medical Basic Information, Area Served and Competitors
Table 48. Precision Medical Major Business
Table 49. Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 50. Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Precision Medical Recent Developments/Updates
Table 52. Precision Medical Competitive Strengths & Weaknesses
Table 53. Aviva Systems Biological Basic Information, Area Served and Competitors
Table 54. Aviva Systems Biological Major Business
Table 55. Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 56. Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Aviva Systems Biological Recent Developments/Updates
Table 58. Aviva Systems Biological Competitive Strengths & Weaknesses
Table 59. Biocept Basic Information, Area Served and Competitors
Table 60. Biocept Major Business
Table 61. Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 62. Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Biocept Recent Developments/Updates
Table 64. Biocept Competitive Strengths & Weaknesses
Table 65. Fluxion Biosciences Basic Information, Area Served and Competitors
Table 66. Fluxion Biosciences Major Business
Table 67. Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 68. Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Fluxion Biosciences Recent Developments/Updates
Table 70. Fluxion Biosciences Competitive Strengths & Weaknesses
Table 71. Greiner Bio-One International GmbH Basic Information, Area Served and Competitors
Table 72. Greiner Bio-One International GmbH Major Business
Table 73. Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 74. Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Greiner Bio-One International GmbH Recent Developments/Updates
Table 76. Greiner Bio-One International GmbH Competitive Strengths & Weaknesses
Table 77. Ikonisys Basic Information, Area Served and Competitors
Table 78. Ikonisys Major Business
Table 79. Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 80. Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Ikonisys Recent Developments/Updates
Table 82. Ikonisys Competitive Strengths & Weaknesses
Table 83. Miltenyi Biotec Basic Information, Area Served and Competitors
Table 84. Miltenyi Biotec Major Business
Table 85. Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 86. Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Miltenyi Biotec Recent Developments/Updates
Table 88. Miltenyi Biotec Competitive Strengths & Weaknesses
Table 89. IVDiagnostics Basic Information, Area Served and Competitors
Table 90. IVDiagnostics Major Business
Table 91. IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 92. IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. IVDiagnostics Recent Developments/Updates
Table 94. IVDiagnostics Competitive Strengths & Weaknesses
Table 95. BioFluidica Basic Information, Area Served and Competitors
Table 96. BioFluidica Major Business
Table 97. BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 98. BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. BioFluidica Recent Developments/Updates
Table 100. BioFluidica Competitive Strengths & Weaknesses
Table 101. Canopus Medical Basic Information, Area Served and Competitors
Table 102. Canopus Medical Major Business
Table 103. Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 104. Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Canopus Medical Recent Developments/Updates
Table 106. Canopus Medical Competitive Strengths & Weaknesses
Table 107. Biolidics Basic Information, Area Served and Competitors
Table 108. Biolidics Major Business
Table 109. Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 110. Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Biolidics Recent Developments/Updates
Table 112. Biolidics Competitive Strengths & Weaknesses
Table 113. Creativ MicroTech Basic Information, Area Served and Competitors
Table 114. Creativ MicroTech Major Business
Table 115. Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 116. Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Creativ MicroTech Recent Developments/Updates
Table 118. Creativ MicroTech Competitive Strengths & Weaknesses
Table 119. LungLife AI Basic Information, Area Served and Competitors
Table 120. LungLife AI Major Business
Table 121. LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 122. LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. LungLife AI Recent Developments/Updates
Table 124. LungLife AI Competitive Strengths & Weaknesses
Table 125. Epic Sciences Basic Information, Area Served and Competitors
Table 126. Epic Sciences Major Business
Table 127. Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 128. Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Epic Sciences Recent Developments/Updates
Table 130. Epic Sciences Competitive Strengths & Weaknesses
Table 131. Rarecells Diagnostics Basic Information, Area Served and Competitors
Table 132. Rarecells Diagnostics Major Business
Table 133. Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 134. Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Rarecells Diagnostics Recent Developments/Updates
Table 136. Rarecells Diagnostics Competitive Strengths & Weaknesses
Table 137. ScreenCell Basic Information, Area Served and Competitors
Table 138. ScreenCell Major Business
Table 139. ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 140. ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. ScreenCell Recent Developments/Updates
Table 142. Menarini Silicon Biosystems Basic Information, Area Served and Competitors
Table 143. Menarini Silicon Biosystems Major Business
Table 144. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product and Services
Table 145. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 146. Global Key Players of Circulating Tumor Cells (CTC) Liquid Biopsy Upstream (Raw Materials)
Table 147. Circulating Tumor Cells (CTC) Liquid Biopsy Typical Customers
LIST OF FIGURES
Figure 1. Circulating Tumor Cells (CTC) Liquid Biopsy Picture
Figure 2. World Circulating Tumor Cells (CTC) Liquid Biopsy Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Circulating Tumor Cells (CTC) Liquid Biopsy Total Market Size (2018-2029) & (USD Million)
Figure 4. World Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (2018-2029) & (USD Million)
Figure 13. Circulating Tumor Cells (CTC) Liquid Biopsy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 16. World Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 18. China Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 23. India Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Circulating Tumor Cells (CTC) Liquid Biopsy by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Circulating Tumor Cells (CTC) Liquid Biopsy Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Circulating Tumor Cells (CTC) Liquid Biopsy Markets in 2022
Figure 27. United States VS China: Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type in 2022
Figure 31. Kits & Reagents
Figure 32. Blood Collection Tubes
Figure 33. Devices
Figure 34. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2018-2029)
Figure 35. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application in 2022
Figure 37. Research & Academic Institutes
Figure 38. Hospitals
Figure 39. Physician Laboratories
Figure 40. Others
Figure 41. Circulating Tumor Cells (CTC) Liquid Biopsy Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Figure 1. Circulating Tumor Cells (CTC) Liquid Biopsy Picture
Figure 2. World Circulating Tumor Cells (CTC) Liquid Biopsy Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Circulating Tumor Cells (CTC) Liquid Biopsy Total Market Size (2018-2029) & (USD Million)
Figure 4. World Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (2018-2029) & (USD Million)
Figure 13. Circulating Tumor Cells (CTC) Liquid Biopsy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 16. World Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 18. China Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 23. India Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Circulating Tumor Cells (CTC) Liquid Biopsy by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Circulating Tumor Cells (CTC) Liquid Biopsy Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Circulating Tumor Cells (CTC) Liquid Biopsy Markets in 2022
Figure 27. United States VS China: Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type in 2022
Figure 31. Kits & Reagents
Figure 32. Blood Collection Tubes
Figure 33. Devices
Figure 34. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2018-2029)
Figure 35. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application in 2022
Figure 37. Research & Academic Institutes
Figure 38. Hospitals
Figure 39. Physician Laboratories
Figure 40. Others
Figure 41. Circulating Tumor Cells (CTC) Liquid Biopsy Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
